Warning letter
Abbott Laboratories Inc.: warning letter of Feb 7, 2000
FDA warning letter UCM068096 · Dallas District Office
Key facts
| Reference number | UCM068096 |
|---|---|
| Company | Abbott Laboratories Inc. |
| Subject | Quality System Regulation/Clinical Chemistry Analyzers |
| Issue date | Feb 7, 2000 |
| Posted date | Feb 7, 2000 |
| Issuing office | Dallas District Office |
| Product type | Unknown |
| CFR sections cited | 820 |
| Country | 3 |
| Inspection city | Irving |
| Inspection ZIP | 75038-4313 |
| Inspection start date | Oct 22, 1999 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: